Business profile & competitive position
Leidos Holdings, Inc. is classified under the Technology sector in the Information Technology Services industry, but in practice the company operates as a science, research, and engineering firm that sells digital and mission-focused solutions primarily to the U.S. government and to commercial customers worldwide. Through four reportable segments—National Security & Digital, Health & Civil, Commercial & International, and Defense Systems—Leidos provides IT modernization, cyber operations, AI-enabled mission software, managed health services, air-traffic systems, energy infrastructure, security-detection products, and advanced maritime, aerospace, and land defense systems.
The fiscal 2025 revenue mix underscores where the business actually earns its money: National Security & Digital contributed 44%, Health & Civil 30%, Commercial & International 13%, and Defense Systems 13%. Approximately 87% of revenue came from U.S. government contracts, either as prime contractor or subcontractor, while only about 8% came from entities located outside the United States. That customer concentration is reinforced by a workforce credential moat: roughly 53% of employees hold U.S. security clearances and roughly 19% are military veterans.
The financial footprint of that moat shows up in the margin and return data rather than in narrative alone. Net margin is 7.9%, while return on equity is 27.6%. A mid-to-high-single-digit net margin is fairly typical for large government-services platforms, but a 27.6% ROE is relatively strong and suggests the company converts its contract base and invested equity into meaningful returns. The combination of long-duration government programs, security-clearance barriers, and recurring managed services points to sticky customer relationships, even if the growth profile is tied more to federal budget cycles than to consumer demand.
Financial posture
Leidos currently carries a market capitalization of $16.7 billion and trades at a trailing P/E of 12.3. For a Technology-sector name, that multiple is on the lower side, indicating the market is pricing in some combination of slower growth, customer concentration risk, or regulatory/budget uncertainty. At the same time, the 7.9% net margin and 27.6% ROE show the company is profitable and efficient with equity capital.
The low beta of 0.57 is another important characteristic. It signals the stock has historically moved roughly half as much as the broader market, which is common for large government contractors because their cash flows are often backstopped by multi-year federal programs. That defensive quality can appeal to investors seeking lower volatility, but it also means Leidos is unlikely to behave like a high-growth software company with outsized revenue expansion.
Overall, the valuation set—the $16.7 billion market cap and 12.3 P/E—sits at a discount relative to the broader technology complex, while the 27.6% ROE provides an offsetting signal about capital efficiency. None of this suggests a directional recommendation; rather, it frames Leidos as a mature, cash-generating contractor valued below many of its tech peers.
Strategic priorities & outlook
The company’s most recent 10-K filing outlines five operational growth pillars: space and maritime; energy infrastructure; digital modernization and cyber; mission software; and managed health services. These pillars cut across the current segment structure and reflect where management is placing its organic and inorganic bets. They also line up with the broader federal technology spending themes—cybersecurity, cloud modernization, artificial intelligence, and resilient infrastructure—that have remained in focus across multiple administrations.
A major near-term priority is the completion and successful integration of Entrust, the identity and data-security acquired through KENE Parent, Inc. Management has tied the deal’s expected benefits to how well Leidos can fold Entrust into its existing digital trust and security portfolio. Beyond M&A integration, the company also wants to grow its commercial health and infrastructure businesses, which today make up smaller slices of the overall revenue pie relative to government work.
Operationally, Leidos spent $187 million on company-funded research and development in fiscal 2025, equal to 1.1% of consolidated revenues. That figure is modest compared with many commercial software peers but is consistent with a services-heavy contractor that funds targeted R&D around mission systems and security products. The filing also emphasizes rapid response to emerging technology trends, including artificial intelligence, suggesting AI integration is expected to be a recurring operational theme rather than a one-time initiative.
Macro & geopolitical exposure
As a government-focused information-technology services provider, Leidos is exposed first and foremost to federal budget appropriations and defense-procurement cycles. Continued funding for cyber operations, IT modernization, space, maritime, and defense systems depends on Congressional appropriations and shifts in defense policy. Any prolonged government shutdown, continuing resolution, or shift in procurement priorities could affect timing of revenue recognition and contract awards.
The company is also exposed to broader geostrategic supply-chain dynamics. A recent headline on minerals needed for advanced lasers—some of which China has restricted—highlights how defense and aerospace supply chains can be disrupted by trade policy and export controls. While Leidos is primarily a services and systems-integration company, hardware programs in defense, maritime, and security detection rely on specialty components and raw materials whose availability can be shaped by geopolitics.
Currency risk is comparatively small because only about 8% of revenue comes from outside the United States. Regulatory risk, on the other hand, is significant: government contractors operate under strict compliance regimes covering security clearances, data handling, cost accounting, and foreign-ownership restrictions. Healthcare-related work adds exposure to federal health spending policy, while AI and cybersecurity work could face evolving oversight around data privacy and autonomous systems.
Recent developments
Recent headlines have touched on ownership changes, market positioning, and supply-chain themes. On September 5, 2026, defenseworld.net reported that Jupiter Topco LLC had taken a position in Leidos Holdings, representing fresh institutional attention. Two days earlier, on September 4, 247wallst.com published a piece on how advanced laser systems depend on minerals that China has cut off, underscoring the broader defense-technology supply-chain risks noted above.
On September 3, 2026, Zacks published two articles on the stock. One asked why Leidos had gained 5.5% since its last earnings report, and the other argued the company is a top value stock for the long term. Together, those items reinforce the narrative that investors are currently focused on Leidos’s valuation discount and its post-earnings price behavior rather than on speculative growth themes.
None of these headlines contain specific guidance changes or material corporate announcements, but they collectively point to three threads: institutional accumulation, geopolitical/raw-material risk for the defense-tech ecosystem, and a value-oriented framing of the equity by market commentators.
Earnings behavior & post-earnings drift
Leidos has an unusually strong earnings track record over the past eight reported quarters: it has beaten consensus estimates in 8 out of 8 quarters, with an average earnings surprise of 16%. That consistency suggests the company’s internal forecasting has generally been conservative relative to the market’s real expectation, or that operational execution has regularly outpaced modeled assumptions.
The post-earnings price behavior, however, is more nuanced. Across the same eight quarters, the average 5-day price move after earnings was +2.15%, classified as an “up” drift. That means that even when the immediate earnings-day reaction has been muted or negative, the stock has tended, on average, to drift higher over the following week.
Looking at the last four quarters in detail shows why this matters for traders:
- August 4, 2026: EPS of $3.26 versus an estimate of $2.91, a 12% surprise. The next-day move was -2.87%, but the five-day drift was +7.88%.
- May 5, 2026: EPS of $3.13 versus $2.90, a 7.9% surprise. The next-day move was -1.67%, and the five-day drift was -6.41%.
- February 17, 2026: EPS of $2.76 versus $2.61, a 5.7% surprise. The next-day move was +6.19%, with a five-day drift of +7.8%.
- November 4, 2025: EPS of $3.05 versus $2.71, a 12.5% surprise. The next-day move was -2.25%, and the five-day drift was -0.65%.
The takeaway from this pattern is that beating estimates does not guarantee a higher stock price immediately. In two of the last four reports, Leidos beat by sizable margins yet traded lower the next day. Over five days, the results have been mixed as well—two strong positive drifts and two negative ones. The next report is scheduled for November 3, 2026, before the market open, with a consensus EPS estimate of $3.05.
Frequently Asked Questions
What does Leidos actually do?
Leidos is a science, research, and engineering company that provides digital and mission-focused IT services to U.S. government and commercial customers. Its four segments are National Security & Digital, Health & Civil, Commercial & International, and Defense Systems, with roughly 87% of fiscal 2025 revenue coming from U.S. government contracts.
How has LDOS historically performed around earnings?
Over the last eight reported quarters, Leidos has beaten consensus EPS estimates every time, with an average surprise of 16%. The average five-day post-earnings drift has been +2.15%, but the immediate next-day reaction has not always been positive, including in the most recent August 2026 quarter.
What are Leidos’s main strategic priorities?
Management’s most recent 10-K highlights five growth pillars: space and maritime; energy infrastructure; digital modernization and cyber; mission software; and managed health services. It also emphasizes integrating the Entrust acquisition, expanding commercial health and infrastructure, and responding to AI trends.
For a deeper dive into how institutional analysts,量化模型, and market positioning are currently viewing Leidos, readers should consult the full institutional verdict and consensus summary on the platform.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-04 | $3.26 | $2.91 | +12% | -2.87% | +7.88% |
| 2026-05-05 | $3.13 | $2.9 | +7.9% | -1.67% | -6.41% |
| 2026-02-17 | $2.76 | $2.61 | +5.7% | +6.19% | +7.8% |
| 2025-11-04 | $3.05 | $2.71 | +12.5% | -2.25% | -0.65% |
| 2025-08-05 | $3.21 | $2.66 | +20.7% | - | - |
| 2025-05-06 | $2.97 | $2.5 | +18.8% | - | - |
Previous LDOS editions
Get the institutional verdict on LDOS
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the LDOS verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.